JGC
J. Goldman & Co Portfolio holdings
AUM
$3.18B
This Quarter Return
+2.34%
1 Year Return
+9.17%
3 Year Return
+56.93%
5 Year Return
+78.85%
10 Year Return
+152.96%
AUM
$2.83B
AUM Growth
+$2.83B
(+23%)
Cap. Flow
+$401M
Cap. Flow
% of AUM
14.17%
Top 10 Holdings %
Top 10 Hldgs %
19.46%
Holding
514
New
135
Increased
90
Reduced
73
Closed
139
Top Buys
| 1 |
Walt Disney
DIS
|
$110M |
| 2 |
3M
MMM
|
$63.5M |
| 3 |
Smith & Nephew
SNN
|
$47.7M |
| 4 |
Modine Manufacturing
MOD
|
$43.2M |
| 5 |
Invesco QQQ Trust
QQQ
|
$41.3M |
Top Sells
| 1 |
Comcast
CMCSA
|
$79.7M |
| 2 |
Netflix
NFLX
|
$67.2M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$67.1M |
| 4 |
Advanced Micro Devices
AMD
|
$53.1M |
| 5 |
SiriusXM
SIRI
|
$51M |
Sector Composition
| 1 | Consumer Discretionary | 20.79% |
| 2 | Industrials | 19.75% |
| 3 | Technology | 14.14% |
| 4 | Healthcare | 12% |
| 5 | Communication Services | 10.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Leslie's
LESL
$60.1M
| $377K | 0.01% |
169,006
-1,171,845
| -87% | -$2.61M |
|
|
HPP
277
Hudson Pacific Properties
HPP
$1.07B
| $366K | 0.01% |
+120,750
| New | +$366K |
|
278
PetMed Express
PETS
$62.4M
| $347K | 0.01% |
+72,000
| New | +$347K |
|
279
Mercado Libre
MELI
$121B
| $340K | 0.01% |
200
-40
| -17% | -$68K |
|
280
Floor & Decor
FND
$8.51B
| $331K | 0.01% |
+3,318
| New | +$331K |
|
281
Gilead Sciences
GILD
$140B
| $312K | 0.01% |
3,373
-60,064
| -95% | -$5.55M |
|
282
Macy's
M
$3.66B
| $306K | 0.01% |
18,078
+3,258
| +22% | +$55.2K |
|
283
Merus
MRUS
$5.01B
| $294K | 0.01% |
7,001
-33,499
| -83% | -$1.41M |
|
284
Nu Holdings
NU
$71.8B
| $290K | 0.01% |
+28,004
| New | +$290K |
|
285
Catalyst Pharmaceutical
CPRX
$2.51B
| $282K | 0.01% |
13,500
| – | – |
|
|
MREO
286
Mereo BioPharma
MREO
$281M
| $278K | 0.01% |
79,387
-175,503
| -69% | -$614K |
|
287
Target
TGT
$42B
| $269K | 0.01% |
1,990
-32,378
| -94% | -$4.38M |
|
288
Hallador Energy
HNRG
$716M
| $257K | 0.01% |
22,414
-93,819
| -81% | -$1.07M |
|
289
TG Therapeutics
TGTX
$4.72B
| $242K | 0.01% |
8,036
-34,751
| -81% | -$1.05M |
|
290
Victoria's Secret
VSCO
$1.79B
| $241K | 0.01% |
5,810
-187,506
| -97% | -$7.77M |
|
291
Icon
ICLR
$13.8B
| $225K | 0.01% |
+1,072
| New | +$225K |
|
292
Sea Limited
SE
$106B
| $212K | 0.01% |
2,000
-2,500
| -56% | -$265K |
|
293
Cardiff Oncology
CRDF
$130M
| $205K | 0.01% |
+47,250
| New | +$205K |
|
294
Leap Therapeutics
LPTX
$12.2M
| $194K | 0.01% |
+67,500
| New | +$194K |
|
295
AMC Entertainment Holdings
AMC
$1.42B
| $166K | ﹤0.01% |
41,825
| – | – |
|
296
Immatics
IMTX
$649M
| $162K | ﹤0.01% |
22,788
| – | – |
|
297
National Vision
EYE
$1.74B
| $155K | ﹤0.01% |
14,922
-1,129
| -7% | -$11.8K |
|
298
Bloomin' Brands
BLMN
$601M
| $148K | ﹤0.01% |
12,115
-15,828
| -57% | -$193K |
|
|
LOGC
299
DELISTED
ContextLogic
LOGC
| $116K | ﹤0.01% |
16,500
-489,635
| -97% | -$3.44M |
|
300
Nu Skin
NUS
$600M
| $111K | ﹤0.01% |
+16,111
| New | +$111K |
|